Bionest

New Models for Primary Care

Concierge medicine? Monthly membership? Could new models of primary care help raise the quality and patient satisfaction of health care while lowering overall costs for those enrolled in commercial and government-funded insurance plans?

Bionest

Zolgensma Launch “On Track,” but Significant Challenges Remain

On July 18, Novartis told analysts its Zolgensma launch was “on track.” Despite the gene therapy’s $2.1 million price tag, the company states the launch is “one of the most successful launches from an access standpoint in rare diseases.” Novartis said it had reached coverage deals with more than 20 commercial insurance plans, covering approximately 40%...

Bionest

Enter the Giants: Amazon, Berkshire Hathaway and J.P. Morgan Take on Healthcare

Recent months have seen a series of corporate actions aimed at reconfiguring healthcare in the United States, beginning with drug store giant CVS’s bid in December 2017 to purchase Aetna, one of the country’s biggest insurers, for about $69 billion. This was followed on January 24 by Apple’s push into electronic healthcare records through an...